Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVAD: Prime-Boost Pneumococcal Vaccination in CVID
NCT01489618Phase 2Terminated
- Sponsor
- Inserm
- Start
- Jun 2009
- Primary completion
- Mar 2013
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of pneumococcal 7-valent conjugate vaccine in pneumococcal infection, sponsored by Inserm. Started Jun 2009; status: terminated.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT01489618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01489618.